If you have tried two or more antidepressants without real relief, you have what clinicians call treatment-resistant depression, and ketamine may be one of the most effective options left to consider. Ketamine for treatment-resistant depression works through a different mechanism than standard antidepressants, often producing relief within hours or days rather than weeks, and clinical trials have shown meaningful response in patients who had not improved on conventional medication. This guide explains what the research actually shows, who is a good candidate, what to expect, and how to decide whether it is the right next step for you.
| What we know
1. Treatment-resistant depression is defined as depression that has not responded adequately to two or more antidepressant medications taken at the right dose and duration. 2. Ketamine acts on the brain’s glutamate system rather than serotonin, which is why it can work rapidly for patients who have not responded to standard antidepressants. 3. Clinical trials show ketamine produces meaningful, rapid antidepressant effects in many patients with treatment-resistant depression, though response varies and maintenance treatment is usually needed. |
What Is Treatment-Resistant Depression?
Treatment-resistant depression is not a separate illness. It is major depressive disorder that has not responded adequately to standard treatment. The most widely used definition is depression that has failed to improve after two or more trials of antidepressant medication, each taken at an adequate dose for an adequate length of time.
If that describes your experience, you are far from alone. A substantial share of people with major depression do not get sufficient relief from the first or second medication they try. That does not mean treatment has failed permanently. It means the treatments tried so far were not the right fit, and a different mechanism may be needed.
This is the gap ketamine was found to fill. It does not work the way SSRIs and SNRIs work, and that difference is precisely why it can help when those medications have not.
How Ketamine Works for Treatment-Resistant Depression
Standard antidepressants act on the brain’s monoamine systems, primarily serotonin, norepinephrine, and dopamine. They typically take four to six weeks to produce a noticeable effect. Ketamine works on a different system entirely. It is an NMDA receptor antagonist, which means it modulates glutamate, the brain’s most abundant excitatory neurotransmitter. Through this glutamate pathway, ketamine promotes synaptic plasticity, the brain’s ability to form new connections between neurons. Researchers believe this is what allows ketamine to interrupt the entrenched patterns of treatment-resistant depression and produce relief in hours rather than weeks. The National Institute of Mental Health has supported and published research on this rapid-acting mechanism, and you can read more through the National Institute of Mental Health.
This mechanism is the reason ketamine is considered specifically for treatment resistance. A patient who has not responded to two serotonin-based medications has, in a sense, shown that the monoamine approach is not enough on its own. Ketamine offers a genuinely different route.
What the Research Shows About Ketamine for TRD
Ketamine is one of the most actively researched treatments in modern psychiatry, and the evidence base for treatment-resistant depression is substantial.
Multiple randomized controlled trials have shown that subanesthetic-dose ketamine produces rapid antidepressant effects in patients with severe treatment-resistant depression, often within hours of a single infusion. Reviews of this research describe ketamine as having both high efficacy and a notably fast onset compared with traditional antidepressants. Some studies have found that repeated ketamine infusions produce improvements comparable to electroconvulsive therapy (ECT) for treatment-resistant depression, which has long been considered one of the most effective options for severe cases.
The FDA’s 2019 approval of esketamine (Spravato), a nasal spray derived from ketamine, was based on this body of evidence and marked the first genuinely new mechanism approved for depression in decades. Research continues, and not every question is settled, but the core finding is consistent: for many patients who have not responded to standard antidepressants, ketamine produces real and rapid improvement.
Who Is a Good Candidate for Ketamine Therapy?
Ketamine is considered when other treatments have not worked. Ketamine for treatment resistant depression is generally explored after standard medication options have been exhausted, and you may be a good candidate if:
- You have been diagnosed with major depressive disorder and have tried two or more antidepressants without sufficient relief.
- Your depression significantly affects your daily functioning, work, or relationships.
- You are looking for faster relief than standard antidepressants can provide, particularly if your symptoms are severe.
- You have experienced suicidal thoughts, where ketamine’s rapid action can be especially valuable under proper clinical supervision.
- You have been screened and cleared for the small number of conditions that make ketamine less appropriate.
Ketamine is not the right choice for everyone. A thorough psychiatric evaluation screens for factors such as uncontrolled high blood pressure, certain cardiac conditions, a history of psychosis, and active substance use. This screening is not a formality. It is how a responsible clinic ensures ketamine is both safe and appropriate for you specifically.
What to Expect From Ketamine Treatment
Ketamine for treatment-resistant depression follows a structured course. Understanding the shape of it helps set realistic expectations.
Treatment begins with a full psychiatric consultation, where your history, prior medications, and goals are reviewed. The standard induction course is six infusions over two to three weeks. Each IV session lasts 40 to 60 minutes with continuous monitoring of your heart rate and blood pressure. During the session, you may experience mild dissociation, a sense of detachment or dreamlike calm, which resolves as the medication wears off.
Many patients notice an improvement in mood, sleep, or motivation within the first few sessions. After the induction course, maintenance infusions every four to eight weeks help sustain the response. For a detailed look at how long the effects last, see our article on how long ketamine lasts for depression. Pairing treatment with integration therapy, where you work with a clinician to apply the experience, tends to produce longer-lasting results.
Success Rates and Honest Expectations
It is important to be straightforward about outcomes. Ketamine is not a guaranteed cure, and no responsible clinic should present it as one.
What the research consistently shows is that a substantial proportion of patients with treatment-resistant depression respond to ketamine, many of them rapidly, and many after they had not responded to multiple other treatments. Some patients experience dramatic relief. Others experience moderate improvement. A minority do not respond and may need a different approach. Response also tends to require ongoing maintenance dosing rather than being permanent after a single course.
The honest framing is this: if you have treatment-resistant depression, ketamine offers a real, evidence-backed chance of relief through a mechanism nothing you have tried so far has used. That is a meaningful reason to consider it, and a consultation is the way to find out whether it fits your situation.
How Ketamine Compares to Other TRD Treatments
Ketamine is one of several options for treatment-resistant depression. It is worth knowing where it sits.
- Versus more antidepressants: trying a third or fourth antidepressant has diminishing odds of success. Ketamine offers a different mechanism rather than another variation on the same one.
- Versus ECT: electroconvulsive therapy is highly effective but involves anesthesia and can carry memory side effects. Some research finds repeated ketamine comparable in effect, with a different and often more tolerable side-effect profile.
- Versus TMS: transcranial magnetic stimulation is another non-medication option for treatment-resistant depression, and Village TMS offers both. The right choice depends on your history and preferences, and a consultation can help you compare them.
None of these is universally best. The point of a psychiatric consultation is to match the treatment to the patient, rather than fitting every patient to one treatment.
Find Out If Ketamine Is Right for Your Depression
If you have treatment-resistant depression and feel like you have run out of options, you may not have. Ketamine therapy at Village TMS in Manhattan is led by Dr. Yuli Fradkin, MD, a psychiatrist with more than 25 years of experience and academic appointments at Beth Israel, Tufts, Yale, and Rutgers, alongside Dr. Elena Bruck, MD. We offer IV, IM, and Spravato, with full psychiatric screening and integration support. Call 646-817-2835 or contact us to book a free consultation.
